Active ingredientTafenoquineCat. No. P-T007-001CAS 106635-80-7Family · Pharmaceutical analytical standards
Tafenoquine
An antimalarial of the 8-aminoquinoline family, related to primaquine, approved in 2018 in the United States and Australia for the radical cure of Plasmodium vivax malaria and for prevention in travellers. This family brings together the active ingredient, labelled standards and nitrosamines.
Did you know?Its half-life is 2-3 weeks: it stays in the body long enough to hit the hypnozoites, the forms of the parasite that lie dormant in the liver and cause relapses.
Go to the active ingredient →Active ingredientTafenoquineCat. No. P-T007-001CAS 106635-80-7
Isotopically labelledN-Nitroso Tafenoquine-d3Cat. No. P-T007-002
Isotopically labelledTafenoquine-d3Cat. No. P-T007-003CAS 1133378-83-2
NitrosamineN-Nitroso TafenoquineCat. No. P-T007-004No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.